Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India-Reference-Cited by-同舟云学术

Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India

Published:2017-11-08 Issue:5 Volume:97 Page:1498-1502
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Pandey Krishna¹,Kumar Rakesh¹,Lal Chandra Shekhar²,Murti Krishna³,Rabi Das Vidya Nand¹,Siddiqui Niyamat Ali⁴,Pal Biplab³,Ali Vahab²,Babu Rajendra³,Das Pradeep⁵,Verma Neena⁶

Affiliation:

1. Department of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India;

2. Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, (Indian Council of Medical Research), Patna, Bihar, India;

3. Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India;

4. Department of Biostatistics, Rajendra Memorial Research Institute of Medical Sciences (Indian Council, of Medical Research), Patna, Bihar, India;

5. Department of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India

6. Department of Pathology, Rajendra Memorial Research Institute of Medical Sciences (Indian Council of, Medical Research), Patna, Bihar, India;

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference22 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

2. Visceral leishmaniasis—current therapeutic modalities;Sundar;Indian J Med Res,2006

3. Post-kala-azar dermal leishmaniasis;Zijlstra;Lancet Infect Dis,2003

4. Epidemiological, clinical and pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India;Thakur;Indian J Med Res,2004

5. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use;Sundar;Clin Infect Dis,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular monitoring of treatment efficacy in human visceral leishmaniasis;Transactions of The Royal Society of Tropical Medicine and Hygiene;2024-01-15

2. Serum Levels of Vitamins and Trace Elements in Patients with Visceral Leishmaniasis: a Systematic Review and Meta-analysis;Biological Trace Element Research;2023-12-18

3. A Novel Automated Framework for QSAR Modeling of Highly Imbalanced Leishmania High-Throughput Screening Data;Journal of Chemical Information and Modeling;2021-06-30

4. Efficacy and safety of treatment for Old World cutaneous leishmaniasis in pediatric patients: a case series;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-05-20

5. A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis;Indian Journal of Dermatology, Venereology and Leprology;2021-02-05